AQXP - Aquinox Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 557.2M
Enterprise Value 3-16.48M
Trailing P/E N/A
Forward P/E 1-10.57
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)2.29
Price/Book (mrq)0.80
Enterprise Value/Revenue 3-0.66
Enterprise Value/EBITDA 6N/A

Trading Information

Stock Price History

Beta (3Y Monthly) 1.05
52-Week Change 3-20.32%
S&P500 52-Week Change 36.70%
52 Week High 33.3300
52 Week Low 32.0000
50-Day Moving Average 32.3851
200-Day Moving Average 32.5356

Share Statistics

Avg Vol (3 month) 350.35k
Avg Vol (10 day) 394.87k
Shares Outstanding 523.54M
Float 10.21M
% Held by Insiders 10.30%
% Held by Institutions 175.53%
Shares Short (Jun 28, 2019) 442.98k
Short Ratio (Jun 28, 2019) 40.99
Short % of Float (Jun 28, 2019) 40.34%
Short % of Shares Outstanding (Jun 28, 2019) 40.18%
Shares Short (prior month May 31, 2019) 455.1k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin -76.68%
Operating Margin (ttm)-41.46%

Management Effectiveness

Return on Assets (ttm)-7.58%
Return on Equity (ttm)-24.36%

Income Statement

Revenue (ttm)25M
Revenue Per Share (ttm)1.06
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)25M
EBITDA N/A
Net Income Avi to Common (ttm)-19.17M
Diluted EPS (ttm)-0.8150
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)74.17M
Total Cash Per Share (mrq)3.15
Total Debt (mrq)496k
Total Debt/Equity (mrq)0.69
Current Ratio (mrq)20.81
Book Value Per Share (mrq)3.04

Cash Flow Statement

Operating Cash Flow (ttm)-18.74M
Levered Free Cash Flow (ttm)-7.08M